Published in Brain Res on December 26, 1994
Targeted manipulation of serotonergic neurotransmission affects the escalation of aggression in adult male Drosophila melanogaster. PLoS One (2010) 1.49
Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation. J Neural Transm (Vienna) (2011) 1.12
Long-term L-DOPA treatment causes indiscriminate increase in dopamine levels at the cost of serotonin synthesis in discrete brain regions of rats. Cell Mol Neurobiol (2007) 1.05
Spontaneous inhibitory synaptic currents mediated by a G protein-coupled receptor. Neuron (2013) 1.00
Presynaptic dopaminergic compartment determines the susceptibility to L-DOPA-induced dyskinesia in rats. Proc Natl Acad Sci U S A (2010) 0.93
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications. Front Neurol (2014) 0.92
The serotonergic system in motor and non-motor manifestations of Parkinson's disease. Exp Brain Res (2013) 0.86
Use of [18F]FDOPA-PET for in vivo evaluation of dopaminergic dysfunction in unilaterally 6-OHDA-lesioned rats. EJNMMI Res (2011) 0.86
Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats. Psychopharmacology (Berl) (2009) 0.84
Role of the primary motor cortex in L-Dopa-induced dyskinesia and its modulation by 5-HT1A receptor stimulation. Neuropharmacology (2011) 0.84
Depression of Serotonin Synaptic Transmission by the Dopamine Precursor L-DOPA. Cell Rep (2015) 0.84
The roles of striatal serotonin and L -amino-acid decarboxylase on L-DOPA-induced Dyskinesia in a Hemiparkinsonian rat model. Cell Mol Neurobiol (2010) 0.83
Chronic L-dopa decreases serotonin neurons in a subregion of the dorsal raphe nucleus. J Pharmacol Exp Ther (2014) 0.80
Presynaptic effects of levodopa and their possible role in dyskinesia. Mov Disord (2014) 0.80
Serotonin System Implication in l-DOPA-Induced Dyskinesia: From Animal Models to Clinical Investigations. Front Neurol (2014) 0.79
The monoamine re-uptake inhibitor UWA-101 improves motor fluctuations in the MPTP-lesioned common marmoset. PLoS One (2012) 0.78
Monoamine reuptake inhibitors in Parkinson's disease. Parkinsons Dis (2015) 0.78
L-DOPA inhibits depolarization-induced [3H]GABA release in the dopamine-denervated globus pallidus of the rat: the effect is dopamine independent and mediated by D2-like receptors. J Neural Transm (Vienna) (2006) 0.77
Differential dopamine receptor occupancy underlies L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. PLoS One (2014) 0.77
SERT-to-DAT ratios in early Parkinson's disease do not correlate with the development of dyskinesias. EJNMMI Res (2013) 0.75
What Mechanisms Are Responsible for the Reuptake of Levodopa-Derived Dopamine in Parkinsonian Striatum? Front Neurosci (2016) 0.75
Palmitoyl Serotonin Inhibits L-dopa-induced Abnormal Involuntary Movements in the Mouse Parkinson Model. Exp Neurobiol (2016) 0.75
The newly synthesized selective Ca2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells. Biochem Biophys Res Commun (1991) 3.04
Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett (1994) 2.27
Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett (1994) 2.17
Photometric assay of dopamine- -hydroxylase activity in human blood. Clin Chem (1972) 2.14
Human dopamine beta-hydroxylase gene: two mRNA types having different 3'-terminal regions are produced through alternative polyadenylation. Nucleic Acids Res (1989) 2.08
Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat Genet (2000) 1.92
Molecular cloning of cDNA and chromosomal assignment of the gene for human phenylethanolamine N-methyltransferase, the enzyme for epinephrine biosynthesis. J Biol Chem (1988) 1.85
A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet (2001) 1.80
A simple and sensitive assay for dopamine-beta-hydroxylase activity by dual-wavelength spectrophotometry. Biochem Med (1974) 1.72
Ablation of cerebellar Golgi cells disrupts synaptic integration involving GABA inhibition and NMDA receptor activation in motor coordination. Cell (1998) 1.69
Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proc Natl Acad Sci U S A (1989) 1.64
Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. Neurosci Lett (1996) 1.64
Inhibitors of purified beef adrenal tyrosine hydroxylase. Biochem Pharmacol (1965) 1.60
New chromogenic substrates for X-prolyl dipeptidyl-aminopeptidase. Anal Biochem (1976) 1.51
Juvenile parkinsonism--some clinical, pharmacological, and neuropathological aspects. Adv Neurol (1984) 1.49
Role of cytokines in inflammatory process in Parkinson's disease. J Neural Transm Suppl (2006) 1.43
Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function. Science (2000) 1.38
Interleukin-10 inhibits both production of cytokines and expression of cytokine receptors in microglia. J Neurochem (1999) 1.34
Targeted disruption of the tyrosine hydroxylase locus results in severe catecholamine depletion and perinatal lethality in mice. J Biol Chem (1995) 1.29
Catecholaminergic neurons containing GABA-like and/or glutamic acid decarboxylase-like immunoreactivities in various brain regions of the rat. Exp Brain Res (1987) 1.24
Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease. Neurosci Lett (1999) 1.21
Migration of dopaminergic neurons in the embryonic mesencephalon of mice. Brain Res Dev Brain Res (1995) 1.19
Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease. Hum Gene Ther (2000) 1.18
Catecholamines and serotonin are differently regulated by tetrahydrobiopterin. A study from 6-pyruvoyltetrahydropterin synthase knockout mice. J Biol Chem (2001) 1.17
Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum Genet (1998) 1.16
Chemically defined neuron groups and their subpopulations in the glomerular layer of the rat main olfactory bulb. Neurosci Res (1995) 1.16
Multiple mRNA forms of human GTP cyclohydrolase I. Biochem Biophys Res Commun (1992) 1.13
Fusaric acid, a hypotensive agent produced by fungi. J Antibiot (Tokyo) (1969) 1.12
Purification of aminopeptidase A in human serum and degradation of angiotensin II by the purified enzyme. Biochim Biophys Acta (1970) 1.12
Structure of the human tyrosine hydroxylase gene: alternative splicing from a single gene accounts for generation of four mRNA types. J Biochem (1988) 1.12
Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH). Am J Med Genet (1997) 1.10
Activities of dipeptidyl peptidase II and dipeptidyl peptidase IV in synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Clin Chem (1989) 1.10
Phenylethanolamine N-methyltransferase and other enzymes of catecholamine metabolism in human brain. Clin Chim Acta (1977) 1.08
Immunotoxin-mediated conditional disruption of specific neurons in transgenic mice. Proc Natl Acad Sci U S A (1995) 1.08
Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease. Gene Ther (2002) 1.08
Expression of mRNAs for neuropeptide receptors and beta-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells. Neurosci Lett (1997) 1.07
Behavioral recovery in 6-hydroxydopamine-lesioned rats by cotransduction of striatum with tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes using two separate adeno-associated virus vectors. Hum Gene Ther (1998) 1.07
Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain. J Neural Transm (Vienna) (2000) 1.06
Immunocytochemical localization of dopamine in the prefrontal cortex of the rat at the light and electron microscopical level. Neuroscience (1987) 1.06
Characterization of mouse and human GTP cyclohydrolase I genes. Mutations in patients with GTP cyclohydrolase I deficiency. J Biol Chem (1995) 1.06
Trans-activation of glutathione transferase P gene during chemical hepatocarcinogenesis of the rat. Proc Natl Acad Sci U S A (1993) 1.04
Serotoninergic, noradrenergic, and peptidergic innervation of Onuf's nucleus of normal and transected spinal cords of baboons (Papio papio). J Comp Neurol (1992) 1.04
Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35. Cancer Res (1986) 1.04
Tyrosine hydroxylase in bovine caudate nucleus. J Neurochem (1971) 1.04
Indirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine. J Neuroimmunol (1995) 1.03
Regional specialization of the rat retina: catecholamine-containing amacrine cell characterization and distribution. J Comp Neurol (1986) 1.02
Molecular genetics of dopa-responsive dystonia. Biol Chem (1999) 1.01
Anatomical distribution and ultrastructural organization of the GABAergic system in the rat spinal cord. An immunocytochemical study using anti-GABA antibodies. Neuroscience (1987) 1.01
A new and highly sensitive voltammetric assay for aromatic L-amino acid decarboxylase activity by high-performance liquid chromatography. Anal Biochem (1979) 1.01
Catecholamine-related enzymes and the biopterin cofactor in Parkinson's disease and related extrapyramidal diseases. Adv Neurol (1984) 1.01
Aromatic L-amino acid decarboxylase activity in central and peripheral tissues and serum of rats with L-DOPA and L-5-hydroxytryptophan as substrates. Biochem Pharmacol (1981) 1.01
Catecholamine synthesis in rabbits with neurogenic hypertension. Circ Res (1969) 1.00
Noradrenaline axon terminals in adult rat neocortex: an immunocytochemical analysis in serial thin sections. Neuroscience (1990) 0.98
Immunohistochemical demonstration of glutaminase in catecholaminergic and serotoninergic neurons of rat brain. Brain Res (1990) 0.98
First demonstration of highly specific and sensitive antibodies against dopamine. Brain Res (1984) 0.98
Tyrosine hydroxylase-like immunoreactive neurons in the striatum of the rat. Neurosci Lett (1989) 0.98
A branch site mutation leading to aberrant splicing of the human tyrosine hydroxylase gene in a child with a severe extrapyramidal movement disorder. Ann Hum Genet (2000) 0.97
Serum glycylproline p-nitroanilidase activity in blood cancers. Clin Chim Acta (1977) 0.97
Stimulus-coupled interaction of tyrosine hydroxylase with 14-3-3 proteins. Biochemistry (1999) 0.96
Striatal neurons with aromatic L-amino acid decarboxylase-like immunoreactivity in the rat. Neurosci Lett (1989) 0.96
Highly sensitive assay for acetylcholinesterase activity by high-performance liquid chromatography with electrochemical detection. J Chromatogr (1985) 0.96
Intrinsic gamma aminobutyric acid receptors modulate the release of catecholamine from canine adrenal gland in situ. J Pharmacol Exp Ther (1986) 0.95
Do tyrosine hydroxylase-immunoreactive neurons in the ventrolateral arcuate nucleus produce dopamine or only L-dopa? J Chem Neuroanat (1989) 0.95
Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene. J Neurosci Res (2001) 0.95
Inactivation of serotonin by sulfotransferase system. J Pharmacol Exp Ther (1969) 0.95
Bradykinase activity of aloe extract. Biochem Pharmacol (1976) 0.95
Quantification of mRNA of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in the substantia nigra in Parkinson's disease and schizophrenia. J Neural Transm Park Dis Dement Sect (1994) 0.95
Increase in level of tumor necrosis factor (TNF)-alpha in 6-hydroxydopamine-lesioned striatum in rats without influence of systemic L-DOPA on the TNF-alpha induction. Neurosci Lett (1999) 0.95
Partial separation and properties of tyrosine hydroxylase from the human pheochromocytoma: effect of norepinephrine. Biochim Biophys Acta (1970) 0.95
In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes. Acta Psychiatr Scand (2012) 0.95
Aromatic L-amino acid decarboxylase- and tyrosine hydroxylase-immunohistochemistry in the adult human hypothalamus. J Chem Neuroanat (1998) 0.95
Conversion of L-tyrosine to 3,4-dihydroxyphenylalanine by cell-free preparations of brain and sympathetically innervated tissues. Biochem Biophys Res Commun (1964) 0.95
Pre- and post-natal ontogeny of serotonergic projections to the rat spinal cord. J Neurosci Res (1989) 0.94
A new and highly sensitive fluorescence assay for collagenase-like peptidase activity. Anal Biochem (1979) 0.94
Inhibition of dopamine beta-hydroxylase by sulfhydryl compounds and the nature of the natural inhibitors. Biochim Biophys Acta (1967) 0.94
Antibodies against gamma-aminobutyric acid: specificity studies and immunocytochemical results. Proc Natl Acad Sci U S A (1984) 0.94
Inhibition of dopamine beta-hydroxylase by 5-alkylpicolinic acid and their hypotensive effects. Chem Pharm Bull (Tokyo) (1969) 0.93
L-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study. Neurosci Lett (1995) 0.92
Bipolarity of duodenal enterochromaffin cells in the rat. Cell Tissue Res (1987) 0.92
Serum aminopeptidases, "angiotensinase," and hypertension. I. Degradation of angiotensin II by human serum. Biochem Pharmacol (1965) 0.92
Demonstration of GABAergic cell bodies in the suprachiasmatic nucleus: in situ hybridization of glutamic acid decarboxylase (GAD) mRNA and immunocytochemistry of GAD and GABA. Neurosci Lett (1989) 0.92
Albumin nitrosylated by activated macrophages possesses antiparasitic effects neutralized by anti-NO-acetylated-cysteine antibodies. J Immunol (1997) 0.92
Evidence for nonsynaptic serotonergic and noradrenergic innervation of the rat dorsal horn and possible involvement of neuron-glia interactions. Neuroscience (1993) 0.92
Cloning and sequencing of cDNA encoding mouse GTP cyclohydrolase I. Biochem Biophys Res Commun (1993) 0.92
Tissue-specific and high-level expression of the human tyrosine hydroxylase gene in transgenic mice. Neuron (1991) 0.92
Catecholamine synthesizing enzymes in 70 cases of functioning and non-functioning phaeochromocytoma and extra-adrenal paraganglioma. Virchows Arch A Pathol Anat Histopathol (1992) 0.92